Muneto Mogi

879 total citations
18 papers, 258 citations indexed

About

Muneto Mogi is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Muneto Mogi has authored 18 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Ophthalmology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Muneto Mogi's work include Glaucoma and retinal disorders (5 papers), Retinal Diseases and Treatments (4 papers) and Retinal Development and Disorders (4 papers). Muneto Mogi is often cited by papers focused on Glaucoma and retinal disorders (5 papers), Retinal Diseases and Treatments (4 papers) and Retinal Development and Disorders (4 papers). Muneto Mogi collaborates with scholars based in United States, Japan and Switzerland. Muneto Mogi's co-authors include Manabu Node, Tetsuya Kajimoto, Kaoru Fuji, Paul Ramage, Gary M. Ksander, Ganesh Prasanna, Frédéric Cumin, Nikolaus Schiering, Frédéric Villard and A. D’Arcy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Muneto Mogi

18 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muneto Mogi United States	10	137	42	32	29	24	18	258
Imteyaz Qamar India	11	147 1.1×	64 1.5×	21 0.7×	34 1.2×	29 1.2×	27	373
Earl F. Kimble Switzerland	10	79 0.6×	14 0.3×	36 1.1×	105 3.6×	18 0.8×	19	411
Hongyue Liu China	10	154 1.1×	11 0.3×	14 0.4×	14 0.5×	23 1.0×	31	326
Katie Southwick United States	7	303 2.2×	153 3.6×	13 0.4×	14 0.5×	43 1.8×	11	464
Andrew T. Placzek United States	9	139 1.0×	12 0.3×	24 0.8×	94 3.2×	5 0.2×	15	325
Sujin Lee United States	11	169 1.2×	5 0.1×	12 0.4×	79 2.7×	9 0.4×	13	326
Harveen Kaur New Zealand	11	224 1.6×	5 0.1×	39 1.2×	81 2.8×	13 0.5×	19	326
Peter G. Klimko United States	12	125 0.9×	118 2.8×	37 1.2×	136 4.7×	19 0.8×	17	426
Whei‐Mei Wu United States	13	148 1.1×	86 2.0×	58 1.8×	41 1.4×	25 1.0×	20	398
Bryan W. Sherman United States	8	181 1.3×	177 4.2×	24 0.8×	69 2.4×	51 2.1×	11	369

Countries citing papers authored by Muneto Mogi

Since Specialization

Citations

This map shows the geographic impact of Muneto Mogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muneto Mogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muneto Mogi more than expected).

Fields of papers citing papers by Muneto Mogi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muneto Mogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muneto Mogi. The network helps show where Muneto Mogi may publish in the future.

Co-authorship network of co-authors of Muneto Mogi

This figure shows the co-authorship network connecting the top 25 collaborators of Muneto Mogi. A scholar is included among the top collaborators of Muneto Mogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muneto Mogi. Muneto Mogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mogi, Muneto, Anisha E. Mendonza, James E. Chastain, et al.. (2023). Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep). Translational Vision Science & Technology. 12(9). 5–5. 7 indexed citations

Argikar, Upendra A., Christopher M. Adams, Ganesh Prasanna, et al.. (2020). Understanding metabolism related differences in ocular efficacy of MGV354. Xenobiotica. 51(1). 5–14. 2 indexed citations

Yi, B. Alexander, Anisha E. Mendonza, Kenneth Kulmatycki, et al.. (2018). Abstract 12892: Safety and Efficacy of LHW090 in Patients With Resistant Hypertension: Results of a Randomized, Double Blind, Parallel Group, Placebo-Controlled Study. Circulation. 1 indexed citations

Stacy, Rebecca C., Kenneth Huttner, James H. Peace, et al.. (2018). A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma. American Journal of Ophthalmology. 192. 113–123. 13 indexed citations

Prasanna, Ganesh, Luciana Ferrara, Christopher M. Adams, et al.. (2018). A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing. Investigative Ophthalmology & Visual Science. 59(5). 1704–1704. 16 indexed citations

Gulati, Sahil, Beata Jastrzębska, Surajit Banerjee, et al.. (2017). Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism. Proceedings of the National Academy of Sciences. 114(13). E2608–E2615. 26 indexed citations

Kansara, Viral, et al.. (2017). Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit. SLAS DISCOVERY. 22(10). 1239–1245. 12 indexed citations

Alexander, Nathan, Kota Katayama, Wenyu Sun, et al.. (2017). Complex binding pathways determine the regeneration of mammalian green cone opsin with a locked retinal analogue. Journal of Biological Chemistry. 292(26). 10983–10997. 12 indexed citations

Yamada, Ken, Margaret E. Brousseau, Yuki Iwaki, et al.. (2017). Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma. Journal of Medicinal Chemistry. 60(20). 8466–8481. 8 indexed citations

10.

Prasanna, Ganesh, et al.. (2016). Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?. European Journal of Pharmacology. 787. 47–56. 12 indexed citations

11.

Crowley, Maura, Karen Anderson, Wei Zheng, et al.. (2016). Ocular complement activation and inhibition in rodent models of endotoxin-induced uveitis. 57(12). 482–482. 1 indexed citations

12.

Schiering, Nikolaus, A. D’Arcy, Frédéric Villard, et al.. (2016). Structure of neprilysin in complex with the active metabolite of sacubitril. Scientific Reports. 6(1). 27909–27909. 50 indexed citations

13.

Urbahns, Klaus, Takeshi Yura, Masaomi Tajimi, et al.. (2012). Tetrahydro-naphthols as orally available TRPV1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(10). 3408–3411. 5 indexed citations

14.

Urbahns, Klaus, Takeshi Yura, Muneto Mogi, et al.. (2011). Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence. Bioorganic & Medicinal Chemistry Letters. 21(11). 3354–3357. 8 indexed citations

15.

Mogi, Muneto, et al.. (2006). Efficient Route to 4a-Methyltetrahydrofluorenes: A Total Synthesis of (±)-Dichroanal B via Intramolecular Heck Reaction. The Journal of Organic Chemistry. 71(7). 2896–2898. 44 indexed citations

16.

Mogi, Muneto, Kaoru Fuji, & Manabu Node. (2004). Asymmetric reduction of methoxy substituted β-tetralones using transfer hydrogenation. Tetrahedron Asymmetry. 15(23). 3715–3717. 23 indexed citations

17.

Hiraoka, B. Yukihiro, Muneto Mogi, Kayoko M. Fukasawa, & Minoru Harada. (1986). Coordinate repression of arginine aminopeptidase and three enzymes of the arginine deiminase pathway in Streptococcus mitis.. PubMed. 12(6). 881–7. 17 indexed citations

18.

Sekiya, S, et al.. (1985). [In vitro sensitivity test of anti-neoplastic agents and their enhancement by biscoclaurine alkaloid].. PubMed. 12(3 Pt 1). 524–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact